Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Net Margin (2020 - 2025)

Historic Net Margin for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 32.62%.

  • Treace Medical Concepts' Net Margin rose 14900.0% to 32.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 23.1%, marking a year-over-year increase of 73700.0%. This contributed to the annual value of 26.78% for FY2024, which is 3100.0% down from last year.
  • Treace Medical Concepts' Net Margin amounted to 32.62% in Q3 2025, which was up 14900.0% from 36.97% recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Net Margin registered a high of 0.9% during Q4 2024, and its lowest value of 57.51% during Q2 2022.
  • For the 5-year period, Treace Medical Concepts' Net Margin averaged around 29.32%, with its median value being 31.11% (2022).
  • Per our database at Business Quant, Treace Medical Concepts' Net Margin tumbled by -327100bps in 2022 and then soared by 280300bps in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Net Margin stood at 19.79% in 2021, then soared by 55bps to 8.86% in 2022, then dropped by -16bps to 10.25% in 2023, then skyrocketed by 91bps to 0.9% in 2024, then plummeted by -3521bps to 32.62% in 2025.
  • Its Net Margin was 32.62% in Q3 2025, compared to 36.97% in Q2 2025 and 30.53% in Q1 2025.